DE602005009154D1 - Human Kinase interacting Protein 2 (KIP2)-related gene variant (KIP2V1) im Zusammenhang mit Prostatakrebs - Google Patents

Human Kinase interacting Protein 2 (KIP2)-related gene variant (KIP2V1) im Zusammenhang mit Prostatakrebs

Info

Publication number
DE602005009154D1
DE602005009154D1 DE602005009154T DE602005009154T DE602005009154D1 DE 602005009154 D1 DE602005009154 D1 DE 602005009154D1 DE 602005009154 T DE602005009154 T DE 602005009154T DE 602005009154 T DE602005009154 T DE 602005009154T DE 602005009154 D1 DE602005009154 D1 DE 602005009154D1
Authority
DE
Germany
Prior art keywords
kip2v1
kip2
prostate cancer
gene variant
related gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005009154T
Other languages
English (en)
Inventor
Ken-Shwo Dai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioptik Technology Inc
Original Assignee
Bioptik Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioptik Technology Inc filed Critical Bioptik Technology Inc
Publication of DE602005009154D1 publication Critical patent/DE602005009154D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DE602005009154T 2005-06-02 2005-06-02 Human Kinase interacting Protein 2 (KIP2)-related gene variant (KIP2V1) im Zusammenhang mit Prostatakrebs Active DE602005009154D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05011950A EP1728799B1 (de) 2005-06-02 2005-06-02 Human Kinase interacting Protein 2 (KIP2)-related gene variant (KIP2V1) im Zusammenhang mit Prostatakrebs

Publications (1)

Publication Number Publication Date
DE602005009154D1 true DE602005009154D1 (de) 2008-10-02

Family

ID=34937190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009154T Active DE602005009154D1 (de) 2005-06-02 2005-06-02 Human Kinase interacting Protein 2 (KIP2)-related gene variant (KIP2V1) im Zusammenhang mit Prostatakrebs

Country Status (3)

Country Link
EP (1) EP1728799B1 (de)
AT (1) ATE405583T1 (de)
DE (1) DE602005009154D1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4271145A (en) 1979-10-22 1981-06-02 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
US20030190622A1 (en) 2002-03-21 2003-10-09 Ken-Shwo Dai Human kinase interacting protein 2 (KIP2)-related gene variant associated with lung cancers

Also Published As

Publication number Publication date
ATE405583T1 (de) 2008-09-15
EP1728799A1 (de) 2006-12-06
EP1728799B1 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
DK1218509T3 (da) Fibroblast vækstfaktorlignende polypeptider
TNSN05300A1 (en) Treatment with anti-vegf antibodies
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
ATE456579T1 (de) Angiopoietin-like 4 protein hemmer kombinationen und deren verwendung
WO2004110345A8 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
ATE542920T1 (de) Modifiziertes menschliches wachstumshormon
ATE475432T1 (de) Arzneimittel für herzversagen
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
WO2004013180A3 (en) Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
CY1114050T1 (el) Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου
MX344216B (es) Productos geneticos expresados de forma diferencial en tumores y su uso.
WO2004048525A3 (en) Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies
WO2007039728A3 (en) AVß6 PEPTIDE LIGANDS AND THEIR USES
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
UA85559C2 (en) Aminobenzophenone compounds
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
WO2004047767A3 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2005026205A3 (de) Differentiell in tumoren exprimierte genprodukte und deren verwendung
ATE405583T1 (de) Human kinase interacting protein 2 (kip2)-related gene variant (kip2v1) im zusammenhang mit prostatakrebs
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
ATE362535T1 (de) Mutiertes cyclin g1 protein
WO2004048546A3 (en) Methods for identifying risk of breast cancer and treatments thereof
DE60117788D1 (de) Menschliche wingless-änhliche gene
WO2005014804A3 (en) Ubiquitin-specific protease
WO2005114216A3 (en) Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Legal Events

Date Code Title Description
8364 No opposition during term of opposition